Table of Content

1 GLP-1 Drug Market Overview
1.1 Product Overview and Scope of GLP-1 Drug
1.2 GLP-1 Drug Segment by Type
1.2.1 Global GLP-1 Drug Market Value Comparison by Type (2024-2034)
1.2.2 Short-acting GLP-1 Drug
1.2.3 Long-acting GLP-1 Drug
1.3 GLP-1 Drug Segment by Application
1.3.1 Global GLP-1 Drug Market Value by Application: (2024-2034)
1.3.2 Obesity
1.3.3 Type 2 Diabetes (T2DM)
1.3.4 Cardiovascular and Cerebrovascular Diseases (CVD)
1.3.5 Non-alcoholic Steatohepatitis (NASH)
1.3.6 Alzheimer's Disease (AD)
1.4 Global GLP-1 Drug Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Drug Revenue 2018-2029
1.4.2 Global GLP-1 Drug Sales 2018-2029
1.4.3 Global GLP-1 Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 GLP-1 Drug Market Competition by Manufacturers
2.1 Global GLP-1 Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global GLP-1 Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global GLP-1 Drug Average Price by Manufacturers (2018-2024)
2.4 Global GLP-1 Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of GLP-1 Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Drug, Product Type & Application
2.7 GLP-1 Drug Market Competitive Situation and Trends
2.7.1 GLP-1 Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest GLP-1 Drug Players Market Share by Revenue
2.7.3 Global GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GLP-1 Drug Retrospective Market Scenario by Region
3.1 Global GLP-1 Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global GLP-1 Drug Global GLP-1 Drug Sales by Region: 2018-2029
3.2.1 Global GLP-1 Drug Sales by Region: 2018-2024
3.2.2 Global GLP-1 Drug Sales by Region: 2024-2029
3.3 Global GLP-1 Drug Global GLP-1 Drug Revenue by Region: 2018-2029
3.3.1 Global GLP-1 Drug Revenue by Region: 2018-2024
3.3.2 Global GLP-1 Drug Revenue by Region: 2024-2029
3.4 North America GLP-1 Drug Market Facts & Figures by Country
3.4.1 North America GLP-1 Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America GLP-1 Drug Sales by Country (2018-2029)
3.4.3 North America GLP-1 Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Drug Market Facts & Figures by Country
3.5.1 Europe GLP-1 Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe GLP-1 Drug Sales by Country (2018-2029)
3.5.3 Europe GLP-1 Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Drug Market Facts & Figures by Country
3.6.1 Asia Pacific GLP-1 Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific GLP-1 Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific GLP-1 Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Drug Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America GLP-1 Drug Sales by Country (2018-2029)
3.7.3 Latin America GLP-1 Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa GLP-1 Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa GLP-1 Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Drug Sales by Type (2018-2029)
4.1.1 Global GLP-1 Drug Sales by Type (2018-2024)
4.1.2 Global GLP-1 Drug Sales by Type (2024-2029)
4.1.3 Global GLP-1 Drug Sales Market Share by Type (2018-2029)
4.2 Global GLP-1 Drug Revenue by Type (2018-2029)
4.2.1 Global GLP-1 Drug Revenue by Type (2018-2024)
4.2.2 Global GLP-1 Drug Revenue by Type (2024-2029)
4.2.3 Global GLP-1 Drug Revenue Market Share by Type (2018-2029)
4.3 Global GLP-1 Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global GLP-1 Drug Sales by Application (2018-2029)
5.1.1 Global GLP-1 Drug Sales by Application (2018-2024)
5.1.2 Global GLP-1 Drug Sales by Application (2024-2029)
5.1.3 Global GLP-1 Drug Sales Market Share by Application (2018-2029)
5.2 Global GLP-1 Drug Revenue by Application (2018-2029)
5.2.1 Global GLP-1 Drug Revenue by Application (2018-2024)
5.2.2 Global GLP-1 Drug Revenue by Application (2024-2029)
5.2.3 Global GLP-1 Drug Revenue Market Share by Application (2018-2029)
5.3 Global GLP-1 Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Eli Lilly GLP-1 Drug Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AstraZeneca GLP-1 Drug Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sanofi GLP-1 Drug Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Pfizer Inc
6.4.1 Pfizer Inc Corporation Information
6.4.2 Pfizer Inc Description and Business Overview
6.4.3 Pfizer Inc GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Inc GLP-1 Drug Product Portfolio
6.4.5 Pfizer Inc Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Novo Nordisk GLP-1 Drug Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Boehringer Ingelheim GLP-1 Drug Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 GlaxoSmithKline (GSK)
6.6.1 GlaxoSmithKline (GSK) Corporation Information
6.6.2 GlaxoSmithKline (GSK) Description and Business Overview
6.6.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolio
6.7.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.8 East China Pharmaceutical Co., Ltd.
6.8.1 East China Pharmaceutical Co., Ltd. Corporation Information
6.8.2 East China Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Portfolio
6.8.5 East China Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Gan & Lee Pharmaceuticals
6.9.1 Gan & Lee Pharmaceuticals Corporation Information
6.9.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolio
6.9.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.10 Tonghua Dongbao
6.10.1 Tonghua Dongbao Corporation Information
6.10.2 Tonghua Dongbao Description and Business Overview
6.10.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Tonghua Dongbao GLP-1 Drug Product Portfolio
6.10.5 Tonghua Dongbao Recent Developments/Updates
6.11 Shanghai Renhui Biopharmaceutical Co., Ltd.
6.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Corporation Information
6.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Description and Business Overview
6.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Portfolio
6.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
6.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information
6.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Description and Business Overview
6.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolio
6.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Drug Industry Chain Analysis
7.2 GLP-1 Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Drug Production Mode & Process
7.4 GLP-1 Drug Sales and Marketing
7.4.1 GLP-1 Drug Sales Channels
7.4.2 GLP-1 Drug Distributors
7.5 GLP-1 Drug Customers
8 GLP-1 Drug Market Dynamics
8.1 GLP-1 Drug Industry Trends
8.2 GLP-1 Drug Market Drivers
8.3 GLP-1 Drug Market Challenges
8.4 GLP-1 Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global GLP-1 Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global GLP-1 Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global GLP-1 Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global GLP-1 Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global GLP-1 Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global GLP-1 Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global GLP-1 Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market GLP-1 Drug Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of GLP-1 Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of GLP-1 Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GLP-1 Drug, Product Type & Application
Table 12. Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP-1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP-1 Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global GLP-1 Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global GLP-1 Drug Sales Market Share by Region (2018-2024)
Table 19. Global GLP-1 Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global GLP-1 Drug Sales Market Share by Region (2024-2029)
Table 21. Global GLP-1 Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global GLP-1 Drug Revenue Market Share by Region (2018-2024)
Table 23. Global GLP-1 Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global GLP-1 Drug Revenue Market Share by Region (2024-2029)
Table 25. North America GLP-1 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America GLP-1 Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America GLP-1 Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America GLP-1 Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America GLP-1 Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe GLP-1 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe GLP-1 Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe GLP-1 Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe GLP-1 Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe GLP-1 Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific GLP-1 Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific GLP-1 Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific GLP-1 Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific GLP-1 Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific GLP-1 Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America GLP-1 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America GLP-1 Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America GLP-1 Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America GLP-1 Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America GLP-1 Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa GLP-1 Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa GLP-1 Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa GLP-1 Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa GLP-1 Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa GLP-1 Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global GLP-1 Drug Sales (K Units) by Type (2018-2024)
Table 51. Global GLP-1 Drug Sales (K Units) by Type (2024-2029)
Table 52. Global GLP-1 Drug Sales Market Share by Type (2018-2024)
Table 53. Global GLP-1 Drug Sales Market Share by Type (2024-2029)
Table 54. Global GLP-1 Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global GLP-1 Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global GLP-1 Drug Revenue Market Share by Type (2018-2024)
Table 57. Global GLP-1 Drug Revenue Market Share by Type (2024-2029)
Table 58. Global GLP-1 Drug Price (US$/Unit) by Type (2018-2024)
Table 59. Global GLP-1 Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global GLP-1 Drug Sales (K Units) by Application (2018-2024)
Table 61. Global GLP-1 Drug Sales (K Units) by Application (2024-2029)
Table 62. Global GLP-1 Drug Sales Market Share by Application (2018-2024)
Table 63. Global GLP-1 Drug Sales Market Share by Application (2024-2029)
Table 64. Global GLP-1 Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global GLP-1 Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global GLP-1 Drug Revenue Market Share by Application (2018-2024)
Table 67. Global GLP-1 Drug Revenue Market Share by Application (2024-2029)
Table 68. Global GLP-1 Drug Price (US$/Unit) by Application (2018-2024)
Table 69. Global GLP-1 Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Eli Lilly GLP-1 Drug Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. AstraZeneca GLP-1 Drug Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Sanofi GLP-1 Drug Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Pfizer Inc Corporation Information
Table 86. Pfizer Inc Description and Business Overview
Table 87. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Pfizer Inc GLP-1 Drug Product
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Novo Nordisk Corporation Information
Table 91. Novo Nordisk Description and Business Overview
Table 92. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Novo Nordisk GLP-1 Drug Product
Table 94. Novo Nordisk Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Boehringer Ingelheim GLP-1 Drug Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. GlaxoSmithKline (GSK) Corporation Information
Table 101. GlaxoSmithKline (GSK) Description and Business Overview
Table 102. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. GlaxoSmithKline (GSK) GLP-1 Drug Product
Table 104. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 105. East China Pharmaceutical Co., Ltd. Corporation Information
Table 106. East China Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product
Table 109. East China Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Gan & Lee Pharmaceuticals Corporation Information
Table 111. Gan & Lee Pharmaceuticals Description and Business Overview
Table 112. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Gan & Lee Pharmaceuticals GLP-1 Drug Product
Table 114. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 115. Tonghua Dongbao Corporation Information
Table 116. Tonghua Dongbao Description and Business Overview
Table 117. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Tonghua Dongbao GLP-1 Drug Product
Table 119. Tonghua Dongbao Recent Developments/Updates
Table 120. Shanghai Renhui Biopharmaceutical Co., Ltd. Corporation Information
Table 121. Shanghai Renhui Biopharmaceutical Co., Ltd. Description and Business Overview
Table 122. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product
Table 124. Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Corporation Information
Table 126. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 127. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product
Table 129. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. GLP-1 Drug Distributors List
Table 133. GLP-1 Drug Customers List
Table 134. GLP-1 Drug Market Trends
Table 135. GLP-1 Drug Market Drivers
Table 136. GLP-1 Drug Market Challenges
Table 137. GLP-1 Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of GLP-1 Drug
Figure 2. Global GLP-1 Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global GLP-1 Drug Market Share by Type in 2022 & 2029
Figure 4. Short-acting GLP-1 Drug Product Picture
Figure 5. Long-acting GLP-1 Drug Product Picture
Figure 6. Global GLP-1 Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global GLP-1 Drug Market Share by Application in 2022 & 2029
Figure 8. Obesity
Figure 9. Type 2 Diabetes (T2DM)
Figure 10. Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 11. Non-alcoholic Steatohepatitis (NASH)
Figure 12. Alzheimer's Disease (AD)
Figure 13. Global GLP-1 Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global GLP-1 Drug Market Size (2018-2029) & (US$ Million)
Figure 15. Global GLP-1 Drug Sales (2018-2029) & (K Units)
Figure 16. Global GLP-1 Drug Average Price (US$/Unit) & (2018-2029)
Figure 17. GLP-1 Drug Report Years Considered
Figure 18. GLP-1 Drug Sales Share by Manufacturers in 2022
Figure 19. Global GLP-1 Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest GLP-1 Drug Players: Market Share by Revenue in 2022
Figure 21. GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global GLP-1 Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America GLP-1 Drug Sales Market Share by Country (2018-2029)
Figure 24. North America GLP-1 Drug Revenue Market Share by Country (2018-2029)
Figure 25. United States GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe GLP-1 Drug Sales Market Share by Country (2018-2029)
Figure 28. Europe GLP-1 Drug Revenue Market Share by Country (2018-2029)
Figure 29. Germany GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific GLP-1 Drug Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific GLP-1 Drug Revenue Market Share by Region (2018-2029)
Figure 36. China GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America GLP-1 Drug Sales Market Share by Country (2018-2029)
Figure 44. Latin America GLP-1 Drug Revenue Market Share by Country (2018-2029)
Figure 45. Mexico GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Colombia GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa GLP-1 Drug Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa GLP-1 Drug Revenue Market Share by Country (2018-2029)
Figure 51. Turkey GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE GLP-1 Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of GLP-1 Drug by Type (2018-2029)
Figure 55. Global Revenue Market Share of GLP-1 Drug by Type (2018-2029)
Figure 56. Global GLP-1 Drug Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of GLP-1 Drug by Application (2018-2029)
Figure 58. Global Revenue Market Share of GLP-1 Drug by Application (2018-2029)
Figure 59. Global GLP-1 Drug Price (US$/Unit) by Application (2018-2029)
Figure 60. GLP-1 Drug Value Chain
Figure 61. GLP-1 Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed